 Connection
Toshitaka Sugawara to Adult
This is a "connection" page, showing publications Toshitaka Sugawara has written about Adult.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.127 |
|
|
|
-
Sugawara T, Rodriguez Franco S, Sherman S, Kirsch MJ, Colborn K, Franklin O, Ishida J, Grandi S, Al-Musawi MH, Gleisner A, Schulick RD, Del Chiaro M. Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: Analysis of the National Cancer Database. Pancreatology. 2024 Dec; 24(8):1340-1347.
Score: 0.042
-
Franklin O, Stoop TF, Rodriguez Franco S, Sugawara T, Ishida H, Halimi A, Colborn K, Gleisner A, Schulick RD, Del Chiaro M. Patterns of treatment and survival in borderline resectable and locally advanced pancreatic cancer. Pancreatology. 2026 Feb; 26(1):154-163.
Score: 0.011
-
Stoop TF, Sugawara T, Oba A, Feld IM, van Roessel S, van Veldhuisen E, Wu YHA, Nishino J, Ali M, Alseidi A, Sauvanet A, Mirabella A, Sa Cunha A, Kokkola A, Groot Koerkamp B, Pietrasz D, Kleive D, Butturini G, Malleo G, van Laarhoven HWM, Frigerio I, Dembinski J, He J, Gagnière J, Kleeff J, Ramia JM, Roberts KJ, Labori KJ, Marino MV, Falconi M, B Mortensen M, Lesurtel M, Bonds M, Chatzizacharias N, Strobel O, Turrini O, Griffin O, Franklin O, Pfeiffer P, Schulick RD, Salvia R, de Wilde RF, Dokmak S, Rodriguez Franco S, Augustinus S, Burgdorf SK, Crippa S, Hackert T, Tarvainen T, Burns WR, Messersmith W, Wilmink JW, Burkhart RA, Del Chiaro M, Besselink MG. Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX. JAMA Oncol. 2025 Mar 01; 11(3):276-287.
Score: 0.011
-
Yamane M, Ishikawa Y, Yamashita H, Morimoto K, Asano D, Sugawara T, Watanabe S, Ueda H, Akahoshi K, Ono H, Tanaka S, Tanabe M. Middle segment preserving pancreatectomy versus total pancreatectomy: a comparative analysis of short- and long-term outcomes. Surg Today. 2025 Jul; 55(7):930-940.
Score: 0.010
-
Yabushita Y, Park JS, Yoon YS, Ohtsuka M, Kwon W, Choi GH, Imamura M, Matsumoto I, Mizuno S, Matsuyama R, Sakata J, Hayashi H, Takeda Y, Katagiri S, Sugawara T, Kobayashi S, Kawasaki Y, Nagano H, Murase K, Kim HS, Nah YW, Jang JY, Yamaue H, Yoon DS, Yamamoto M, Choi D, Nakamura M, Kim KH, Endo I. Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea. J Hepatobiliary Pancreat Sci. 2024 Jul; 31(7):481-491.
Score: 0.010
-
Yee EJ, Torphy RJ, Thielen ON, Easwaran L, Franklin O, Sugawara T, Bartsch C, Garduno N, McCarter MM, Ahrendt SA, Schulick RD, Del Chiaro M. Radiologic Occult Metastases in Pancreatic Cancer: Analysis of Risk Factors and Survival Outcomes in the Age of Contemporary Neoadjuvant Multi-agent Chemotherapy. Ann Surg Oncol. 2024 Sep; 31(9):6127-6137.
Score: 0.010
-
Kobayashi Y, Kiya Y, Sugawara T, Nishioka Y, Hashimoto M, Shindoh J. Expanded Makuuchi's criteria using estimated indocyanine green clearance rate of future liver remnant as a safety limit for maximum extent of liver resection. HPB (Oxford). 2019 08; 21(8):990-997.
Score: 0.007
-
Shindoh J, Kawamura Y, Kobayashi Y, Kiya Y, Sugawara T, Akuta N, Kobayashi M, Suzuki Y, Ikeda K, Hashimoto M. Platelet-Albumin Score as a Sensitive Measure for Surgical Risk Prediction and Survival Outcomes of Patients with Hepatocellular Carcinoma. J Gastrointest Surg. 2019 01; 23(1):76-83.
Score: 0.007
-
Nishioka Y, Yoshioka R, Gonoi W, Sugawara T, Yoshida S, Hashimoto M, Shindoh J. Fluorine-18-fluorodeoxyglucose positron emission tomography as an objective substitute for CT morphologic response criteria in patients undergoing chemotherapy for colorectal liver metastases. Abdom Radiol (NY). 2018 05; 43(5):1152-1158.
Score: 0.007
-
Sasaki K, Shindoh J, Nishioka Y, Sugawara T, Margonis GA, Andreatos N, Pawlik TM, Hashimoto M. Postoperative low hepatitis C virus load predicts long-term outcomes after hepatectomy for hepatocellular carcinoma. J Surg Oncol. 2018 Apr; 117(5):902-911.
Score: 0.007
-
Shindoh J, Nishioka Y, Yoshioka R, Sugawara T, Sakamoto Y, Hasegawa K, Hashimoto M, Kokudo N. KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion. Ann Surg Oncol. 2016 06; 23(6):1890-6.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|